Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5177536
Max Phase: Preclinical
Molecular Formula: C64H81N15O10
Molecular Weight: 1220.45
Associated Items:
ID: ALA5177536
Max Phase: Preclinical
Molecular Formula: C64H81N15O10
Molecular Weight: 1220.45
Associated Items:
Canonical SMILES: CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O
Standard InChI: InChI=1S/C64H81N15O10/c1-3-4-19-48(72-37(2)80)57(83)76-52-34-55(81)68-27-12-11-22-47(56(65)82)73-60(86)51(32-41-35-70-45-20-9-7-17-43(41)45)75-58(84)49(23-13-28-69-64(66)67)74-59(85)50(31-38-25-26-39-15-5-6-16-40(39)30-38)77-62(88)54-24-14-29-79(54)63(89)53(78-61(52)87)33-42-36-71-46-21-10-8-18-44(42)46/h5-10,15-18,20-21,25-26,30,35-36,47-54,70-71H,3-4,11-14,19,22-24,27-29,31-34H2,1-2H3,(H2,65,82)(H,68,81)(H,72,80)(H,73,86)(H,74,85)(H,75,84)(H,76,83)(H,77,88)(H,78,87)(H4,66,67,69)/t47-,48-,49-,50+,51-,52-,53-,54-/m0/s1
Standard InChI Key: DZVWJVDDMNYSPR-LMHASDJUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1220.45 | Molecular Weight (Monoisotopic): 1219.6291 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Gimenez LE, Noblin TA, Williams SY, Mullick Bagchi S, Ji RL, Tao YX, Jeppesen CB, Conde-Frieboes KW, Sawyer TK, Grieco P, Cone RD.. (2022) Demonstration of a Common DPhe7 to DNal(2')7 Peptide Ligand Antagonist Switch for Melanocortin-3 and Melanocortin-4 Receptors Identifies the Systematic Mischaracterization of the Pharmacological Properties of Melanocortin Peptides., 65 (8.0): [PMID:35404053] [10.1021/acs.jmedchem.1c01295] |
Source(1):